STAT1 and metabolic dysfunction-associated steatotic liver disease: Our previously reported results demonstrate that RPV promotes beneficial effects in different murine models of liver injury, including a nutritional model of MASLD; importantly, STAT1-mediated pathways have been shown to be fundamental for eliminating activated HSCs via apoptosis and for decreasing collagen production [3].